BCAX EBITDA Growth
Bicara Therapeutics Inc · EBITDA Growth
BCAX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-80.85%period ending
BCAX TTM EBITDA YoY % (-3.75% → -80.85%)
Year-over-year change
High-resolution chart · PNG
BCAX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -80.8532% | |
| -70.615% | |
| -103.135% | |
| -66.4294% | |
| -30.9162% | |
| -32.4891% | |
| -3.7486% |